<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="41889">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01941524</url>
  </required_header>
  <id_info>
    <org_study_id>502-14-02215338-09873</org_study_id>
    <nct_id>NCT01941524</nct_id>
  </id_info>
  <brief_title>Brain Oxygenation and Function of Preterm Newborns During Administration of Two Different Surfactant Preparations</brief_title>
  <official_title>Assessment of the Cerebral Tissue Oxygenation and the Bioelectrical Brain Activity of Preterm Newborns During Administration of Two Different Surfactant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poznan University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poznan University of Medical Sciences</source>
  <oversight_info>
    <authority>Poland: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether there are differences in bioelectrical
      function (measured by amplitude integrated electroencephalography) and brain oxygenation
      (measured by near infrared spectroscopy) while and after instillation of two different
      surfactant preparations.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Bandwidth, lower and upper margin of amplitude integrated signal while using two different surfactant preparations (beractant and poractant.</measure>
    <time_frame>12 hours after surfactant instillation</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of brain oxygenation (rSO2) while using two different surfactant preparations (beractant and poractant).</measure>
    <time_frame>12 hours after surfactant instillation</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Differences in pulmonary function parameters while using two different surfactant preparations.</measure>
    <time_frame>12 hours after surfactant instillation</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Expiratory tidal volume (Vte), minute ventilation(MV) and dynamic compliance are going to be measured.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Respiratory Distress Syndrome, Newborn</condition>
  <condition>Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>Poractant goup</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Newborns, who will be monitored by amplitude integrated electroencephalography (aEEG) and near infrared spectroscopy (NIRS) during poractant instillation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Beractant group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Newborns who will be monitored by aEEG and NIRS during beractant instillation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Poractant alfa instillation</intervention_name>
    <description>aEEG and NIRS monitoring during poractant alfa instilation</description>
    <arm_group_label>Poractant goup</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Beractant instillation</intervention_name>
    <description>aEEG and NRs monitoring during beractant instillation</description>
    <arm_group_label>Beractant group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  26-30 gestational age

          -  surfactant instillation

        Exclusion Criteria:

          -  congenital heart disease

          -  congenital central nervous disorder

          -  congenital genetic disorders
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tomasz Szczapa, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Poznan University of Medical Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tomasz Szczapa, M.D.</last_name>
    <phone>+48 607 576 457</phone>
    <email>tszczapa@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Neonatology</name>
      <address>
        <city>Poznan</city>
        <state>Great Poland</state>
        <zip>60-535</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tomasz Szczapa, M.D.</last_name>
      <phone>+48 607 576 457</phone>
      <email>tszczapa@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Łukasz Karpiński, Physician</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 18, 2013</lastchanged_date>
  <firstreceived_date>June 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Poznan University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Tomasz Szczapa</investigator_full_name>
    <investigator_title>doctor of medical science</investigator_title>
  </responsible_party>
  <keyword>Brain oxygenation</keyword>
  <keyword>NIRS</keyword>
  <keyword>aEEG</keyword>
  <keyword>surfactant</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pulmonary Surfactants</mesh_term>
    <mesh_term>Beractant</mesh_term>
    <mesh_term>Poractant alfa</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
